Springer is founding a new journal Food Digestion, dedicated to a quickly growing area of research – food science combined with the physiology of digestion. The journal will publish two issues in 2010 and increase to four issues in 2011.

View original post here: 
Food Science And Clinical Science Joined For The First Time In A Periodical

Related posts:

1. USDA Joins Global Alliance To Reduce Greenhouse Gas Emissions, Increase Food SecurityThe U.S. Agriculture Department (USDA) said on Wednesday it has joined the Global Research Alliance, which aims to reduce greenhouse gas emissions and increase access to food worldwide, Reuters reports....
2. Explore The Science Of Familiar Things — And Discover The ‘Joy Of Chemistry’If you're like most people, you probably think chemistry is too difficult to bother with outside of school and too clinical to be any fun. But chemistry offers a magic...
3. Data Indicates Rising Adoption Of Technology In Canadian Clinical TrialsA research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical...
4. Given A Choice, Arthritis Patients Take More Conservative Clinical ApproachA recent study suggests that increasing patient responsibility for making medical decisions may decrease their willingness to accept risky treatment options. Details of this proof-of-concept study appear in the December...
5. National Science Foundation Grants Will Further Understanding Of Decomposition And DiseaseTwo Kent State University assistant professors recently received funding from the National Science Foundation (NSF) to continue research beneficial to understanding the environment. The three grants total $890,000. Christopher Blackwood,...
6. AFFiRiS AG: Interim Analysis Of Clinical Phase I Data Triggered Decision To Move Alzheimer’s Vaccine Candidate AD02 Into Clinical Phase II TestingAFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II...
7. Adeona Announces Publication Of Results Of 160 Patient Phase 2 Clinical Trial Of Oral DnaJP1 For Rheumatoid ArthritisAdeona Pharmaceuticals, Inc. (AMEX: AEN) announced the publication in the journal Arthritis & Rheumatism of results of a 160-patient, six-month, double-blind, placebo-controlled Phase 2 clinical trial using the company's oral...
8. Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial SitesCuremark LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM-AT,...
9. PuriCore Announces Promising Clinical Results For Vashe(R) Wound Therapy In Post-Operative Care Of Skin Grafts On BurnsPuriCore (LSE:PURI), the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, announced results of a randomized clinical trial showing the...
10. PanGenex Expands Clinical Trial Sites After Promising Pre-Clinical Data About Lower Coronary Arterial Calcium Scores In Cardiac PatientsPanGenex Corporation (Pink Sheets: PGCX) ("PanGenex" or "the Company") announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company...
11. New Method Targets Cancerous Tumors Without Harming Healthy Cells (Science Daily)Researchers have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects....
12. First Ever Clinical Study Shows Dental Stem Cells Regrow BoneIn a statement today, StemSave(TM), Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the November issue of the European Cells and...
13. Successful Phase I/II Clinical Trial For BiondVax Pharmaceuticals’ Universal Flu VaccineBiondVax Pharmaceuticals Ltd. (TASE: BNDK), an Israeli biopharmaceutical company at the forefront of the development of a Universal Influenza Vaccine, announced the success of the Phase I/II clinical trial of...
14. ASH To Encourage High School Students To Pursue Biomedical Research Through Special Symposium And Science CurriculumThe American Society of Hematology (ASH) will host its annual High School Student Symposium at the New Orleans Marriott on Thursday, December 3, at 8:00 a.m. CST. The symposium, which...
15. Medifacts International Drives Innovation In Telemedicine For Clinical TrialsMedifacts International, Inc., one of the largest global providers of noninvasive cardiovascular diagnostic services, announced that they are once again leading the Cardiovascular Safety Services marketplace in innovation, expertise, and...